Lynne Peterson is the Senior Writer for Trends-in-Medicine.

Here is the medical news to watch for May 3-9, 2021.

Hematology: The World Federation of Hemophilia’s International Musculoskeletal (MSK) Congress will take place virtually May 3-7. The 5-day meeting will have a mix of educational sessions, free paper abstract submission presentations, and interactive workshops, focusing on the most current knowledge on musculoskeletal approaches to bleeding disorders. This meeting is not just for hematologists but also orthopedic surgeons.

Interventional radiology: The International Symposium on Endovascular Therapy (ISET), which starts on May 9 will be a hybrid meeting, with limited in-person attendance in Miami and unlimited virtual access. The first day will have symposia on the essentials of endovascular therapy, non-invasive vascular diagnosis, endovascular emergencies, chronic limb ischemia, and more.

Oncology

  • The ESMO Breast Cancer meeting will take place virtually May 5-8. The focus will be on the latest advances in adjuvant, neoadjuvant, and immunotherapy as well as cutting edge surgical research, new agents on the horizon, diagnostics, and biomarkers.
  • The IASLC CT Screening Symposium: Forefront Advances in Lung Cancer Screening, a two-day interactive virtual event focused on lung cancer screening technologies and best practices, will take place virtually May 7-8.

Ophthalmology

  • The Association for Research in Vision and Ophthalmology (ARVO) virtual meeting is continuing through May 7. Among the data to watch: A therapy for geographic atrophy, Apellis Pharmaceuticals’ pegcetacoplan, a C3 inhibitor.
  • The Hawaiian Eye and Retina 2021 meeting on May 8-14 is hybrid this year, so you can either fly to Maui or watch it virtually. On site at the Grand Wailea Hotel, there will be open-air as well as indoor sessions. The hotel will even have a luau on May 13. In terms of education, there will be an update on clinical trials in geographic atrophy, updates on central serous retinopathy, infectious uveitis, ocular tumors, eyelid surgery, diabetic macular edema, and aesthetics – and that’s just the first two days!

Psychiatry: The American Psychiatric Association (APA) virtual meeting finishes up on May 3.

Regulatory news

  • The FDA’s Center for Devices and Radiological Health (CDRH) is hosting a virtual public meeting on May 4 on patient-generated health data (PGHD) throughout the life cycle of medical devices.
  • The FDA’s Center for Biologics Evaluation and Research (CBER) is holding a virtual workshop on May 6 for patient advocates on patient engagement and regenerative medicine – e.g., cell and gene therapies.

Rheumatology: The FDA’s Arthritis Advisory Committee will meet virtually on May 6 to review ChemoCentryx’s avacopan to treat anti-neutrophil cytoplasmic antibody-associated vasculitis.

Lynne Peterson, Contributing Writer, Senior Writer for Trends-in-Medicine

Cat ID: 118

Topic ID: 78,118,730,118,22,24,324,697,192,147,725,158,925,240,96,170,323,696

Author